Why it was recalled
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
Product description
Valsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-5815-77.
Lot numbers, UPCs & expiration codes
Lot Numbers: 3063783 3063784 3063785 3064092 3064093 3064094 3070349 3070350 3070351 3070352 3070353 3070354 3079030 3079031 3079032 3079033 3080011 3080224 3081498 3081500 3087126 3088476
Where it was sold
Product was distributed throughout the United States to several major distributors, including Puerto Rico.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0327-2019
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Dec 4, 2018
- FDA report date
- Dec 19, 2018
- Quantity
- 129,754 HDPE bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Mylan Laboratories Limited, (Nashik FDF)
Original FDA data
Every field from FDA enforcement report D-0327-2019, exactly as published.
Show all FDA fields
- City
- Sinnar, Nashik District
- Status
- Ongoing
- Country
- India
- Event ID
- 81707
- Address
- F-4 F-12, Malegaon M.I.D.C., Sinnar
- Code information
- Lot Numbers: 3063783 3063784 3063785 3064092 3064093 3064094 3070349 3070350 3070351 3070352 3070353 3070354 3079030 3079031 3079032 3079033 3080011 3080224 3081498 3081500 3087126 3088476
- Report date
- Dec 19, 2018
- Product type
- Drugs
- Recall number
- D-0327-2019
- Classification
- Class II
- Recalling firm
- Mylan Laboratories Limited, (Nashik FDF)
- Product quantity
- 129,754 HDPE bottles
- Reason for recall
- GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Valsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-5815-77.
- Distribution pattern
- Product was distributed throughout the United States to several major distributors, including Puerto Rico.
- Recall initiation date
- Dec 4, 2018
- Initial firm notification
- Press Release
- Center classification date
- Dec 14, 2018